To resume proliferation, quiescent cells activate EGF, RAS, TGFβ1, and TGFβ3, which upregulation have been attributed to cause higher malignancy in breast tumors (Chen et al, 2015; Lo et al, 2006). Here, EGF is linked to breast neoplasm.